Welcome to our dedicated page for Univ Health Svc news (Ticker: UHS), a resource for investors and traders seeking the latest updates and insights on Univ Health Svc stock.
Universal Health Services, Inc. reports developments tied to its hospital and healthcare-services operations through subsidiaries that operate acute care hospitals, behavioral health facilities, outpatient facilities and ambulatory care access points in the United States, the United Kingdom and Puerto Rico. Recurring news includes quarterly and annual financial results, operating outlooks, earnings-call schedules and presentations at healthcare conferences.
Company updates also cover capital-allocation and financing actions, including cash dividends, share repurchases, credit-agreement changes and other material corporate events. News about UHS commonly links operating performance to its acute care and behavioral health platforms, as well as governance and shareholder communication matters.
Universal Health Services, Inc. (UHS) announced a cash dividend of $0.20 per share, payable on December 15, 2022. Shareholders must be on record by December 01, 2022. UHS is a leading provider of hospital and healthcare services, operating numerous facilities across the United States, Puerto Rico, and the United Kingdom.
Universal Health Services, Inc. (UHS) has announced that Steve Filton, the Executive Vice President and CFO, will participate in two upcoming healthcare conferences in November 2022. The first presentation is scheduled for November 10, 2022, at 11:00 a.m. ET, during the 31st Annual Credit Suisse Healthcare Conference in Rancho Palos Verdes, California. The second is on November 17, 2022, at 12:00 p.m. ET, at the 2022 Wolfe Research Healthcare Conference in New York City. Live webcasts will be available on the company's website, with replays accessible for 90 days.
Universal Health Services (UHS) reported a net income of $182.8 million ($2.50 per diluted share) for Q3 2022, down from $218.4 million ($2.60 per diluted share) in Q3 2021. Net revenues rose by 5.7% to $3.336 billion year-over-year. Adjusted net income was $185.8 million ($2.54 per diluted share), down from $224.1 million ($2.67 per diluted share) in 2021. EBITDA fell to $421.7 million from $441.5 million in the previous year. For the nine-month period, net income was $500.8 million ($6.71 per diluted share), compared to $752.5 million ($8.83 per diluted share) in 2021, while net revenues increased by 6.3% to $9.952 billion.
Universal Health Services, Inc. (UHS) has appointed Edward H. Sim as Executive Vice President and President of Acute Care, following Marvin Pember's retirement announcement. Sim, with nearly 30 years of experience, will oversee UHS Acute Care operations starting December 5. Marc D. Miller, President and CEO, highlighted Sim's background, including his role as COO at Centura Health, managing $5 billion in revenues. In 2021, UHS reported annual revenues of approximately $12.6 billion and continues to expand its healthcare services across the U.S. and abroad.
Universal Health Services, Inc. (NYSE: UHS) announced it will report its third-quarter results for the period ending September 30, 2022, after market close on October 25, 2022. A conference call for investors and analysts is scheduled for October 26, 2022, at 9:00 a.m. Eastern Time. The call will be webcast live via the company's website, with registration required for telephone participation. Universal Health Services is among the largest hospital companies in the U.S., operating acute care hospitals and behavioral health facilities across the U.S., U.K., and Puerto Rico.
Universal Health Services (NYSE: UHS) will have Steve Filton, Executive VP and CFO, participate in a fireside chat at Morgan Stanley's 20th Annual Global Healthcare Conference on September 14, 2022, at 1:30 PM EDT. A live audio webcast will be accessible on the company's website, with a replay available for 90 days after the event. UHS is a major player in healthcare management, operating over 400 facilities across 39 U.S. states, Washington D.C., the UK, and Puerto Rico, focusing on patient care needs for over 40 years.
Universal Health Services (UHS) reported a net income of $164.1 million, or $2.20 per diluted share, for Q2 2022, a significant drop from $325 million or $3.79 per share in Q2 2021. Despite a 3.9% increase in net revenues to $3.323 billion, adjusted net income also fell to $163.9 million from $322.3 million year-over-year. EBITDA decreased to $384.5 million from $581.8 million, largely impacted by reduced patient volumes due to declining COVID-19 cases, and ongoing staffing shortages. UHS increased its share repurchase program authorization to $1.21 billion.
Universal Health Services (NYSE: UHS) announced a cash dividend of $0.20 per share to be distributed on September 15, 2022. Shareholders of record as of September 1, 2022 will receive this payment. UHS, a leading hospital management company, operates 405 facilities across the U.S., Washington, D.C., the U.K., and Puerto Rico, focusing on providing comprehensive healthcare services for over 40 years. This dividend marks a continued commitment to returning value to shareholders.
Universal Health Services, Inc. (UHS) announces that it will release its second quarter earnings results for the period ending June 30, 2022, after market close on July 25, 2022. An investor conference call is scheduled for 9:00 a.m. ET on July 26, 2022. The presentation will be available via a live webcast on the company's website, with a replay accessible for one year post-event. UHS is a major hospital operator in the United States, UK, and Puerto Rico, encompassing acute care and behavioral health facilities.
Universal Health Services, Inc. (UHS) revised its 2022 financial forecast, citing a significant decline in operating results during April and May. The adjusted net income per diluted share is now estimated at $2.05 to $2.15 for Q2, driven by lower patient volumes and revenues at acute care hospitals, mainly due to a decline in COVID-related patients. The new projections indicate net revenues of approximately $13.235 billion to $13.371 billion, down 1.4% to 2.4% from previous estimates. Adjusted EBITDA is projected at $1.635 billion to $1.712 billion, and Adjusted EPS-diluted at $9.60 to $10.40, representing decreases of 19.3% from prior forecasts.